Abstract:BACKGROUND:A combination of paclitaxel with antineoplastic agents or paclitaxel alone was used clinically for the treatment of metastatic breast cancer. However, paclitaxel has poor water solubility and limited effect on some metastatic breast cancers. Hence, novel paclitaxel derivatives are in demand. In addition, the inducible nitric oxide synthase inhibitor, and aminoguanidine has a synergistic antitumor effect with chemotherapeutics.OBJECTIVE:This study aims to design and synthesize the paclitaxel-aminoguanidine conjugates. Upon cellular internalization, the novel paclitaxel-aminoguanidine conjugates could release paclitaxel and aminoguanidine with the aid of esterase and weak acids in cancer cells.METHODS:Paclitaxel-aminoguanidine conjugates were synthesized using click chemistry. The biological activity of paclitaxel-aminoguanidine conjugates was evaluated by MTT assay, determination of nitric oxide, analysis of apoptosis and cell cycle, and wound healing assay.RESULTS:Here, a novel paclitaxel-aminoguanidine conjugate was synthesized using click chemistry. Compared with paclitaxel, the water solubility of paclitaxel-aminoguanidine conjugates increased obviously. Upon cellular internalization, the novel paclitaxel-aminoguanidine conjugates released paclitaxel and aminoguanidine to synergistically inhibit the proliferation and metastasis of breast cancer cells with the aid of esterase and weak acids in cancer cells. The results of the MTT assay showed that compared with paclitaxel or the mixture of paclitaxel and aminoguanidine, the cytotoxicity of compound 4 against 4T1 cells was enhanced. As for apoptosis induced by these compounds, the paclitaxel-aminoguanidine conjugates also had a stronger ability to induce apoptosis than paclitaxel or the mixture of paclitaxel and aminoguanidine. The results of the scratch test showed that the anti-metastatic effect of the conjugate was the strongest among these tested compounds.CONCLUSION:These findings indicate that paclitaxel-aminoguanidine conjugate is a promising anticancer agent worthy of further study.

Synthesis and Biological Evaluation of Paclitaxel-aminoguanidine Conjugates for Suppressing Breast Cancer.

Synthesis of Ph-Sensitive, Water-Soluble Paclitaxel Prodrugs Based on Norbornene-Functional Polylactide by Copper-Free Click Chemistry

Enhanced Antitumor Effect of Novel Dual-Targeted Paclitaxel Liposomes

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.

A Dual Bispecific Hydrolysis Peptide-Drug Conjugate Responsive to Micro-Acidic and Reduction Circumstance Promotes Antitumor Efficacy in Triple-Negative Breast Cancer

Synthesis and Biological Evaluation of an Anticancer Drug Delivery System: Poly(l-γ-glutamyl-l-carbocisteine)-paclitaxel Nanoconjugate.

Heparin-Paclitaxel Conjugates As Drug Delivery System: Synthesis, Self-Assembly Property, Drug Release, and Antitumor Activity

The Use of Amino Acid Linkers in the Conjugation of Paclitaxel with Hyaluronic Acid As Drug Delivery System: Synthesis, Self-Assembled Property, Drug Release, and in Vitro Efficiency

Paclitaxel-Octreotide Conjugates in Tumor Growth Inhibition of A549 Human Non-Small Cell Lung Cancer Xenografted into Nude Mice

Synthesis and Biological Evaluation of Paclitaxel and Vorinostat Co-Prodrugs for Overcoming Drug Resistance in Cancer Therapy in Vitro.

Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids

A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxel.

Synthesis of Paclitaxel Derivatives for Remote Loading into Liposomes and Improved Therapeutic Effect

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

Anti-Tumor Synergistic Effect Of A Dual Cancer-Specific Recombinant Adenovirus And Paclitaxel On Breast Cancer

Comparison of Action of Paclitaxel and Poly(l-Glutamic Acid)-Paclitaxel Conjugate in Human Breast Cancer Cells.

Paclitaxel-betulinic Acid Hybrid Nanosuspensions for Enhanced Anti-Breast Cancer Activity.

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models

A Novel Combinational Nanodrug Delivery System Induces Synergistic Inhibition of Lung Adenocarcinoma Cells In vitro

Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release

Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.